Key result
A 60-year-old female developed warfarin-induced skin necrosis upon restarting the medication after a brief interruption, despite having been on it for two years without complication.
Case Report (n=1)
No
A prior history of being on warfarin without complication does not preclude the development of warfarin-induced skin necrosis upon restarting the medication.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to necrosis risk on warfarin restart after interruption; leaves open mechanisms and prevention strategies.
Skin necrosis is a relatively rare, potentially fatal side effect of warfarin. It is most commonly reported within 10 days of initiation of therapy in warfarin-naïve patients. We report an atypical case of warfarin-induced skin necrosis upon recommencement of warfarin in a non-naïve warfarin patient.
No takes yet. Share an insight, caveat, or question.
Sklar et al. (2017) conducted a case report in Warfarin-induced skin necrosis (n=1). Warfarin was evaluated on Development of skin necrosis. A 60-year-old female developed warfarin-induced skin necrosis upon restarting the medication after a brief interruption, despite having been on it for two years without complication.
Synapse has enriched 10 related papers. Consider them for comparative context: